Eli Lilly
LLY
LLY
3,538 hedge funds and large institutions have $705B invested in Eli Lilly in 2024 Q2 according to their latest regulatory filings, with 274 funds opening new positions, 1,514 increasing their positions, 1,318 reducing their positions, and 116 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3,538
Holders Change
+104
Holders Change %
+3.03%
% of All Funds
51.46%
Holding in Top 10
547
Holding in Top 10 Change
+93
Holding in Top 10 Change %
+20.48%
% of All Funds
7.96%
New
274
Increased
1,514
Reduced
1,318
Closed
116
Calls
$8.06B
Puts
$9.73B
Net Calls
-$1.67B
Net Calls Change
-$2.04B
Top Buyers
| 1 |
UBS AM
Chicago,
Illinois
|
+$1.21B |
| 2 |
Swedbank
Stockholm,
Sweden
|
+$1.08B |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.01B |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$985M |
| 5 |
Morgan Stanley
New York
|
+$591M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$2.46B |
| 2 |
Primecap Management
Pasadena,
California
|
-$1.48B |
| 3 |
Lilly Endowment
Indiananapolis,
Indiana
|
-$1.39B |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$1.01B |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$538M |